Your browser doesn't support javascript.
loading
Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00.
Munzone, Elisabetta; Gray, Kathryn P; Fumagalli, Caterina; Guerini-Rocco, Elena; Láng, István; Ruhstaller, Thomas; Gianni, Lorenzo; Kammler, Roswitha; Viale, Giuseppe; Di Leo, Angelo; Coates, Alan S; Gelber, Richard D; Regan, Meredith M; Goldhirsch, Aron; Barberis, Massimo; Colleoni, Marco.
Afiliação
  • Munzone E; Division of Medical Senology, European Institute of Oncology, Milan, Italy. Elisabetta.Munzone@ieo.it.
  • Gray KP; International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, and Harvard T.H Chan School of Public Health, Boston, MA, USA.
  • Fumagalli C; Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy.
  • Guerini-Rocco E; Division of Pathology and Laboratory Medicine, Department of Oncology and Hemato-oncology, European Institute of Oncology and University of Milan, Milan, Italy.
  • Láng I; National Institute of Oncology, Budapest, Hungary.
  • Ruhstaller T; Breast Center St. Gallen, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.
  • Gianni L; Divisione di Oncologia, Ospedale degli Infermi, Rimini, Dipartimento di Oncologia ed Ematologia, AUSL della Romagna, Rimini, Italy.
  • Kammler R; Translational Research Coordination and Central Pathology Office, International Breast Cancer Study Group Coordinating Center, Bern, Switzerland.
  • Viale G; Division of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan and International Breast Cancer Study Group Central Pathology Office, Milan, Italy.
  • Di Leo A; Hospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, and International Breast Cancer Study Group, Prato, Italy.
  • Coates AS; International Breast Cancer Study Group and University of Sydney, Sydney, Australia.
  • Gelber RD; International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School and Frontier Science & Technology Research Foundation, Boston, MA, USA.
  • Regan MM; International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Goldhirsch A; Scientific & Clinical Evaluation Board, European Institute of Oncology and International Breast Cancer Study Group, Milan, Italy.
  • Barberis M; Division of Pathology and Laboratory Medicine, European Institute of Oncology and University of Milan, Milan, Italy.
  • Colleoni M; Division of Medical Senology, European Institute of Oncology, and International Breast Cancer Study Group, Milan, Italy.
Breast Cancer Res Treat ; 170(2): 351-360, 2018 Jul.
Article em En | MEDLINE | ID: mdl-29589138
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Neoplasias de Mama Triplo Negativas / Mutação Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Neoplasias de Mama Triplo Negativas / Mutação Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article